137 related articles for article (PubMed ID: 10512068)
1. Thalidomide-induced toxic epidermal necrolysis.
Horowitz SB; Stirling AL
Pharmacotherapy; 1999 Oct; 19(10):1177-80. PubMed ID: 10512068
[TBL] [Abstract][Full Text] [Related]
2. Steven's Johnson syndrome with toxic epidermal necrolysis due to thalidomide in a case of multiple myeloma.
Das A; Sil A; Mishra V; Das NK
Indian J Pharmacol; 2014; 46(5):557-9. PubMed ID: 25298592
[TBL] [Abstract][Full Text] [Related]
3. Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma.
Boruah PK; Bolesta S; Shetty SM
Pharmacotherapy; 2011 Sep; 31(9):925. PubMed ID: 21923596
[TBL] [Abstract][Full Text] [Related]
4. Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy.
Colagrande M; Di Ianni M; Coletti G; Peris K; Fargnoli MC; Moretti L; Lapecorella M; Tabilio A
Int J Hematol; 2009 Jan; 89(1):76-79. PubMed ID: 19052692
[TBL] [Abstract][Full Text] [Related]
5. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
[TBL] [Abstract][Full Text] [Related]
6. Toxic epidermal necrolysis induced by thalidomide and dexamethasone treatment for multiple myeloma.
Hwang S; Woo Y; Kim M; Park HJ
Int J Dermatol; 2017 Feb; 56(2):e35-e37. PubMed ID: 27805271
[No Abstract] [Full Text] [Related]
7. Severe cutaneous reactions associated with the use of human immunodeficiency virus medications.
Rotunda A; Hirsch RJ; Scheinfeld N; Weinberg JM
Acta Derm Venereol; 2003; 83(1):1-9. PubMed ID: 12636014
[TBL] [Abstract][Full Text] [Related]
8. Dermatologic emergencies.
Usatine RP; Sandy N
Am Fam Physician; 2010 Oct; 82(7):773-80. PubMed ID: 20879700
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide in toxic epidermal necrolysis.
Klausner JD; Kaplan G; Haslett PA
Lancet; 1999 Jan; 353(9149):324. PubMed ID: 9929047
[No Abstract] [Full Text] [Related]
10. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
[TBL] [Abstract][Full Text] [Related]
11. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
[TBL] [Abstract][Full Text] [Related]
12. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.
Ghislain PD; Roujeau JC
Dermatol Online J; 2002 Jun; 8(1):5. PubMed ID: 12165215
[TBL] [Abstract][Full Text] [Related]
13. Paracetamol induced Stevens-Johnson syndrome--toxic epidermal necrolysis overlap syndrome.
Biswal S; Sahoo SS
Int J Dermatol; 2014 Aug; 53(8):1042-4. PubMed ID: 24673330
[TBL] [Abstract][Full Text] [Related]
14. Dermatologic side effects of thalidomide in patients with multiple myeloma.
Hall VC; El-Azhary RA; Bouwhuis S; Rajkumar SV
J Am Acad Dermatol; 2003 Apr; 48(4):548-52. PubMed ID: 12664018
[TBL] [Abstract][Full Text] [Related]
15. Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?
Garcia-Doval I; LeCleach L; Bocquet H; Otero XL; Roujeau JC
Arch Dermatol; 2000 Mar; 136(3):323-7. PubMed ID: 10724193
[TBL] [Abstract][Full Text] [Related]
16. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
[TBL] [Abstract][Full Text] [Related]
17. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis.
Wolkenstein P; Latarjet J; Roujeau JC; Duguet C; Boudeau S; Vaillant L; Maignan M; Schuhmacher MH; Milpied B; Pilorget A; Bocquet H; Brun-Buisson C; Revuz J
Lancet; 1998 Nov; 352(9140):1586-9. PubMed ID: 9843104
[TBL] [Abstract][Full Text] [Related]
18. Toxic epidermal necrolysis.
Lacy JA
Nutr Clin Pract; 1991 Feb; 6(1):18-20. PubMed ID: 1775102
[TBL] [Abstract][Full Text] [Related]
19. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
20. Erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis in lenalidomide-treated patients.
Castaneda CP; Brandenburg NA; Bwire R; Burton GH; Zeldis JB
J Clin Oncol; 2009 Jan; 27(1):156-7. PubMed ID: 19047275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
